UMIN000048277Completed
Renal protective effects of tofogliflozin and changes in clinical parameters affecting renal function in patients with type 2 diabetes
Department of Diabetes, Metabolism and Kidney Disease, Edogawa HospitalUniversity Hospital Medical Information Network
VerifiedUniversity Hospital Medical Information Network
Study focus
- Disease/Condition
- type 2 diabetes
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Mar 01, 2019
- End date
- N/A
ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with multiple complications
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000048277
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000048277 through Pure Global AI's free database. This phase not specified trial is sponsored by Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital and is currently Completed. The study focuses on type 2 diabetes.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.